Glenmark Pharma

The market may see some consolidation with a positive bias. Below are some short-term trading ideas to consider.

Trade Spotlight: How should you trade Bandhan Bank, Apollo Tyres, Birlasoft, Glenmark Pharma, Tata Communications, and others on December 3?

The bears may gain strength if the market convincingly breaks the 20-day EMA and the midline of the Bollinger Bands. Below are some short-term trading ideas to consider.

Buy Glenmark Pharma; target of Rs 2170: Motilal Oswal

Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2170 in its research report dated November 17, 2025.

Glenmark signs cancer drug licensing deal with China's Hengrui for $18 million upfront with $1.1 billion in milestone payments

The deal involves an upfront payment of $18 million by Glenmark Pharma and Hengrui will be eligible for regulatory and milestone payments of up to $1.093 billion.

Glenmark shares higher as subsidiary gets $700 million from NYSE-listed AbbVie in licensing deal

The exclusive global licensing pact features $700 million as upfront payment and $1.225 billion in milestones, in addition to tiered, double-digit royalties on net sales.

Chartist Talk: SBI Securities’ Sudeep Shah picks Swiggy; RBL Bank, Glenmark Pharma set for fresh upmove

All major moving averages are currently flat, typically a sign of consolidation or range-bound movement in the Nifty 50, said Sudeep Shah of SBI Securities.

Glenmark shares rally over 2.5 percent on muti-nation Phase 3 trial for cancer drug Envafolimab

An exchange filing by Glenmark said that it has received approval from the Drugs Controller General of India (DCGI) to commence patient enrollment and dosing in India.

Trade Spotlight: How should you trade Coal India, ITC Hotels, GMDC, Pondy Oxides, Paytm, Glenmark Pharma, HDFC Bank, and others on September 04?

The uptrend is expected to strengthen if the frontline indices decisively surpass short- and medium-term moving averages. Below are some short-term trading ideas to consider.

Buy Glenmark Pharma; target of Rs 2400: Motilal Oswal

Motilal Oswal is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated August 18, 2025.

Glenmark Pharma shares fall 4% as Q1 earnings show fails to impress

Glenmark Pharmaceuticals shares fell up to 4 percent in trade on August 18, after the pharma player's earnings show for the June quarter disappointed.

Pharma stocks fall up to 2% as Trump threatens steep tariffs on drug imports

The US government has long sought to shift pharmaceutical manufacturing back to domestic soil, citing both economic and national security concerns.

Gainers & Losers: Top 10 stocks that moved the most on July 11

About 1510 shares advanced, 2341 shares declined, and 150 shares were unchanged.

Buy Glenmark Pharma; target of Rs 2430: Motilal Oswal

Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2430 in its research report dated July 11, 2025.

Mutual funds trump retail in Glenmark surge as cancer drug deal sends stock soaring

Institutional bets pay off big as Glenmark Pharma locks into upper circuit after AbbVie licensing deal

Glenmark Pharma shares rally 15% to record high after mega licensing deal for its cancer drug

The licensing deal is the largest one by any Indian pharma company, and the deal value is above expectations, said Nomura.

Glenmark arm IGI licenses cancer drug to AbbVie for upfront $700 mn with $1.22 bn in milestone payment

AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China

Chartist Talks: Sudeep Shah of SBI Securities explains why he is bullish on these 6 stocks but flags Glenmark Pharma as overbought

Glenmark is in an extreme overbought zone as per RSI range shift rules. Hence, Sudeep Shah of SBI Securities believes it is likely to slide into the period of consolidation for the short term.

Trade Spotlight: How should you trade Eicher Motors, DMart, Indus Towers, Chambal Fertilisers, MCX India, BHEL, CDSL, and others on June 24?

The market is expected to continue its rangebound trading in the upcoming sessions amid the ongoing Middle East conflict. Below are some short-term trading ideas to consider.

Trade Spotlight: How should you trade Persistent Systems, Glenmark Pharma, Eternal, Jindal Stainless, L&T Finance, United Spirits and others on June 9?

The momentum is expected to sustain in the upcoming session, though some profit booking at higher levels cannot be ruled out. Below are some short-term trading ideas to consider.

Buy Glenmark Pharma; target of Rs 1690: Motilal Oswal

Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 1690 in its research report dated May 26, 2025.

Glenmark Pharma shares drop 3% on lower-than-expected Q4 results: Should you buy, sell, hold?

Glenmark Pharma: Despite strong growth in Europe and domestic formulations, muted demand in India and pressure in diabetes products weighed on overall performance

Chartist Talks: In April, ICICI Securities' Dharmesh Shah sees Nifty at 24,200, bets on these 3 stock ideas

However, Nifty's move towards 24,200 would not be in a linear manner as bouts of volatility in the backdrop of looming US tariff announcement would prevail wherein, according to Dharmesh Shah of ICICI Securities.